Position in VERA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,936,114
+$4,038,844 QoQ
Shares Held
581,126
+11.9% QoQ
Ownership
0.806%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 217 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. VERA ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in VERA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,936,114 | 581,126 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $20,897,270 | 519,445 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $23,963,807 | 473,219 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $13,404,211 | 461,260 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $10,849,613 | 460,510 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $10,046,578 | 418,259 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,242,244 | 455,007 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $16,146,260 | 365,300 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,224,476 | 365,519 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,060,216 | 372,454 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,949,820 | 321,835 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,051,358 | 295,504 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,453,280 | 277,463 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,500,667 | 193,385 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,428,056 | 125,481 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,447,879 | 114,870 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,530,716 | 112,470 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,569,969 | 109,407 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,080,231 | 77,853 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,029,114 | 59,315 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||